-
Mashup Score: 1How does COVID-19 impact patients with lymphoma receiving B-cell-depleting immunotherapy? - 3 year(s) ago
During the EHA2021 Virtual Congress, the Lymphoma Hub spoke with Caroline Besson, Université de Paris, Paris, FR. We asked, How does COVID-19 impact patients with lymphoma receiving B-cell-depleting immunotherapy?
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular, patients with hematologic malignancies have been significantly affected by this crisis at every stage of their treatment.
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
💉 Did you catch the latest advice for transplant patients on #COVID19 vaccination? Read this article on the @lymphomahub now! 👉 https://t.co/AYDwGbETUK 👈 #LymHubSS #Lymphoma #lymsm #SESCOVID19
-
-
Mashup Score: 0
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Western countries, predominantly affecting older patients and characterized by several alterations in the way the immune system functions.
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🦠 Study finds ibrutinib may offer protection against the cytokine storm for patients with #CLL who develop #COVID19. Find out more here: 👉 https://t.co/tR803Hqzqz 👈 #lymsm #SESCOVID19 #lymphoma
-
-
Mashup Score: 1
The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular, patients with hematologic malignancies have been significantly affected by this crisis at every stage of their treatment.
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
💉 What’s the latest advice for transplant patients on #COVID19 vaccination? Read this article on the @lymphomahub now! 👉 https://t.co/AYDwGbnj3c 👈 #LymHubSS #Lymphoma #lymsm #SESCOVID19
-
-
Mashup Score: 2
The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular, patients with hematologic malignancies have been significantly affected by this crisis at every stage of their treatment.
Source: aml-hub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
💉 What’s the latest advice for transplant patients on #COVID19 vaccination? Read this article on the @AML_Hub now! 👉 https://t.co/Q6lN8TPqQe 👈 #AML #AMLsm #SESCOVID19
-
-
Mashup Score: 2
Purpose Nationwide mass vaccination against Covid-19 started in Israel in late 2020. Soon we identified on [18F]FDG PET-CT studies vaccine-associated hypermetabolic lymphadenopathy (VAHL) in axillary or supraclavicular lymph nodes (ASLN) ipsilateral to the vaccination site. Sometimes, differentiation between the malignant and benign nature of the hypermetabolic lymphadenopathy (HLN) could not be…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👀Looking for a weekend read? 💉@DanCohe97783443 shared this article on Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine with us! 👉https://t.co/CSNdErmHNq 👈 #COVID19 #SESCOVID19 #lymsm
-
-
Mashup Score: 0
The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular, patients with hematologic malignancies have been significantly affected by this crisis at every stage of their treatment.
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
💉 What’s the latest advice for transplant patients on #COVID19 vaccination? Read this article on the @MM_Hub now! 👉 https://t.co/FleaBXTRQ1 👈 #MM #MMHubSS #MultipleMyeloma #mmsm #SESCOVID19
-
-
Mashup Score: 1COVID-19 | Multiple Myeloma Hub - 3 year(s) ago
Online resource for healthcare professionals, providing information, news & support relating to multiple myeloma
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
To stay up today with the latest information on COVID-19 and MM stay tuned into our hub. https://t.co/u7Pd9SBnKk @MM_Hub, #SESCOVID19
-
-
Mashup Score: 0NCCN COVID-19 vaccination recommendations for patients with hematologic malignancies - 3 year(s) ago
Patients with cancer are at high risk of COVID-19-associated complications and, accordingly, the preliminary recommendations issued by the National Comprehensive Cancer Network (NCCN) COVID-19 Vaccination Advisory Committee state that all cancer patients should be prioritized for COVID-19 vaccination, and caregivers and household/close contacts should also be considered for early immunization.
Source: aml-hub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
💉 Preliminary recommendations for #COVID19 vaccination in cancer patients have been published by the @NCCN. 👉 https://t.co/5CdL1tyvsg 👈 #SESCOVID19 #SARSCoV2 #COVID19Vaccine #Leusm #Leukemia
-
-
Mashup Score: 0NCCN COVID-19 vaccination recommendations for patients with hematologic malignancies - 3 year(s) ago
Patients with cancer are at high risk of COVID-19-associated complications and, accordingly, the preliminary recommendations issued by the National Comprehensive Cancer Network (NCCN) COVID-19 Vaccination Advisory Committee state that all cancer patients should be prioritized for COVID-19 vaccination, and caregivers and household/close contacts should also be considered for early immunization.
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#NCCN2021 | Find below the recently published NCCN #COVID19Vaccination recommendations for patients with hematologic diseases #covax #SESCOVID19 https://t.co/NXqXaIzmtZ
-
👀 During #EHA21, @lymphomahub spoke with Caroline Besson, @Univ_Paris. We asked, How does #COVID19 impact patients with #lymphoma receiving B-cell-depleting immunotherapy? Watch here: 👉 https://t.co/n1WwM8Er9k 👈 #lymsm #SESCOVID19 #lymhubss https://t.co/Q7Ux8shrfx